[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality
J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis
Objective As COVID-19 spreads across the world, there are concerns that people with
asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic …
asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic …
Does asthma affect morbidity or severity of COVID-19?
K Matsumoto, H Saito - Journal of Allergy and Clinical Immunology, 2020 - jacionline.org
Coronavirus disease 2019 (COVID-19) has afflicted at least 4.9 million patients worldwide,
causing more than 328,000 deaths to date. This pandemic impacts not only social and …
causing more than 328,000 deaths to date. This pandemic impacts not only social and …
Asthma and COVID-19 risk: a systematic review and meta-analysis
Background Individual case series and cohort studies have reported conflicting results in
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …
The association of asthma with COVID-19 mortality: An updated meta-analysis based on adjusted effect estimates
H Hou, J Xu, Y Li, Y Wang, H Yang - The Journal of Allergy and Clinical …, 2021 - Elsevier
Background The association of asthma with the risk for mortality among coronavirus disease
2019 (COVID-19) patients is not clear. Objective To investigate the association between …
2019 (COVID-19) patients is not clear. Objective To investigate the association between …
[HTML][HTML] Asthma and COVID-19: a systematic review
Background Severe coronavirus disease-19 (COVID-19) presents with progressive
dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with …
dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with …
[HTML][HTML] Asthma and COVID-19: a dangerous liaison?
C Lombardi, F Gani, A Berti, P Comberiati… - Asthma research and …, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking …
Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis
S Liu, Y Cao, T Du, Y Zhi - The Journal of Allergy and Clinical Immunology …, 2021 - Elsevier
Background The impact of asthma on coronavirus disease 2019 (COVID-19) remains largely
unknown. Objective To investigate the asthma prevalence among patients with COVID-19 …
unknown. Objective To investigate the asthma prevalence among patients with COVID-19 …
Asthma and COVID-19: what do we know now
A Hughes-Visentin, ABM Paul - Clinical Medicine Insights …, 2020 - journals.sagepub.com
The COVID-19 pandemic has presented challenges in symptomology identification,
diagnosis, management and follow-up in common respiratory diseases, and in particular …
diagnosis, management and follow-up in common respiratory diseases, and in particular …
Asthma-associated risk for COVID-19 development
C Skevaki, A Karsonova, A Karaulov, M Xie… - Journal of allergy and …, 2020 - Elsevier
The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …